Description
Sporanox (itraconazole) is an azole antifungal listed in our Medications for infections directory and prescribed for specified fungal infections and HIV infection (1.1) (2.1). Administered via the oral route, Sporanox is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Sporanox is a medication containing the active pharmaceutical ingredient itraconazole, classified pharmacologically as an azole antifungal (2.1). It is clinically indicated for the management of specified fungal infections and HIV infection as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Medications for infections section of our catalogue, patients and prescribers frequently review Sporanox alongside related therapies such as Diflucan (Fluconazole), Fluconazole, Posanol (Posaconazole), and Voriconazole.
Official Indications and Usage
Indications and usage Sporanox ® (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: Blastomycosis, pulmonary and extrapulmonary Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy. Specimens for fungal cultures and other relevant laboratory studies (wet mount, histopathology, serology) should be obtained before therapy to isolate and identify causative organisms. Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, antiinfective therapy should be adjusted accordingly. (1.1)
Mechanism of Action and Pharmacology
In vitro studies have demonstrated that itraconazole inhibits the cytochrome P450-dependent synthesis of ergosterol, which is a vital component of fungal cell membranes. (1.1)
What are Fungal infections?
Fungal infections can affect skin, mucous membranes, or internal organs. The organism, site, and severity determine treatment. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Fungal infections condition guide for appointment questions and related therapies (2.1).
What is HIV?
HIV affects the immune system. Treatment uses a complete antiretroviral regimen selected and monitored by an experienced care team. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete HIV condition guide for appointment questions and related therapies (2.1).
Ordering Sporanox from Canada for U.S. Delivery
U.S. patients can order Sporanox (Itraconazole) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Sporanox |
| Chemical / Generic Name | Itraconazole |
| Pharmacological Class | Azole Antifungal |
| Therapeutic Category | Medications for infections |
| Molecular Weight | 705.64. g/mol (2.1) |
| Bioavailability | ~55% (1.1) |
| Elimination Half-Life | ~16 to 28 hours (1.1) |
| Time to Peak Plasma Level (Tmax) | 2 to 5 hours (2.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus |
| Routes of Administration | Oral |
| Primary Indications | Specified Fungal Infections And Hiv Infection |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| FDA UNII Identifier | 304NUG5GF4 |
| NLM RxNorm Concept ID (RxCUI) | 311204, 833164 |
| FDA Application License | NDA020083 |
| Official DailyMed SetID | a4d555fa-787c-40fb-bb7d-b0d4f7318fd0 |
| Catalogue Index Links | Letter S Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
Dosage and administration Sporanox ® (itraconazole) Capsules should be taken with a full meal to ensure maximal absorption. Sporanox ® (itraconazole) Capsules must be swallowed whole. Sporanox ® Capsules is a different preparation than Sporanox ® Oral Solution and should not be used interchangeably. Treatment of Blastomycosis and Histoplasmosis The recommended dose is 200 mg once daily (2 capsules). If there is no obvious improvement, or there is evidence of progressive fungal disease, the dose should be increased in 100-mg increments to a maximum of 400 mg daily. (1.1)
Administration Guidance
Take Sporanox orally at the same time(s) each day as directed on your prescription label (1.1). Check with your pharmacist whether your specific formulation should be taken with a meal or on an empty stomach, and swallow extended-release or film-coated tablets whole without crushing, chewing, or splitting unless the tablet is scored and your prescriber has instructed you to do so.
Missed Dose Guidance
If you miss a scheduled dose of Sporanox, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Sporanox is itraconazole (2.1).
Excipients and Formulation Carriers
Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).
Cautions and important safety information
Boxed Warning
Warning: Congestive Heart Failure, Cardiac Effects and Drug Interactions Congestive Heart Failure and Cardiac Effects Sporanox ® (itraconazole) Capsules should not be administered for the treatment of onychomycosis in patients with evidence of ventricular dysfunction such as congestive heart failure (CHF) or a history of CHF. If signs or symptoms of congestive heart failure occur during administration of Sporanox ® Capsules, discontinue administration. When itraconazole was administered intravenously to dogs and healthy human volunteers, negative inotropic effects were seen. Drug Interactions Coadministration of a number of CYP3A4 substrates are contraindicated with Sporanox ®. (1.1)
Contraindications
Contraindications Congestive Heart Failure Sporanox ® (itraconazole) Capsules should not be administered for the treatment of onychomycosis in patients with evidence of ventricular dysfunction such as congestive heart failure (CHF) or a history of CHF. Drug Interactions Coadministration of a number of CYP3A4 substrates are contraindicated with Sporanox ®. (1.1)
Key Clinical Precautions
Before starting or continuing Sporanox, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Heart failure: Fluid retention or cardiovascular workload changes may precipitate or worsen congestive heart failure in susceptible patients. Report sudden weight gain, shortness of breath, or ankle and leg swelling to your healthcare provider.
- Fetal toxicity and pregnancy considerations: This medication may cause fetal harm when administered to a pregnant patient. Discuss pregnancy planning, effective contraception, and safe treatment alternatives with your healthcare provider.
- Malignancy monitoring: Follow age-appropriate and treatment-specific screening recommendations discussed with your prescribing specialist.
- Hepatic (liver) effects: Elevations in liver enzymes or rare cases of severe hepatic injury have been reported. Baseline and periodic liver function tests may be recommended; seek medical evaluation for jaundice, dark urine, or persistent right-upper-abdominal pain.
- Respiratory depression: Monitor closely for slowed, shallow, or difficult breathing, particularly during initiation, dose titration, or when combined with other central nervous system depressants.
- Cardiac conduction and QT interval: Caution is advised in patients with known arrhythmias, bradycardia, electrolyte disturbances (hypokalemia or hypomagnesemia), or concomitant QT-prolonging medications.
Pregnancy, Lactation, and Special Populations
Pregnancy Teratogenic Effects Itraconazole was found to cause a dose-related increase in maternal toxicity, embryotoxicity, and teratogenicity in rats at dosage levels of approximately 40-160 mg/kg/day (1-4 times the MRHD based on body surface area comparisons), and in mice at dosage levels of approximately 80 mg/kg/day (1 time the MRHD based on body surface area comparisons). Itraconazole has been shown to cross the placenta in a rat model. In rats, the teratogenicity consisted of major skeletal defects; in mice, it consisted of encephaloceles and/or macroglossia. There are no studies in pregnant women. (1.1)
Interactions
Official Drug Interaction Overview
Drug Interactions Effect of Sporanox ® on Other Drugs Itraconazole and its major metabolite, hydroxy-itraconazole, are potent CYP3A4 inhibitors. Itraconazole is an inhibitor of the drug transporters P-glycoprotein and breast cancer resistance protein (BCRP). Consequently, Sporanox ® has the potential to interact with many concomitant drugs resulting in either increased or sometimes decreased concentrations of the concomitant drugs. Increased concentrations may increase the risk of adverse reactions associated with the concomitant drug which can be severe or life-threatening in some cases (e.g., QT prolongation, torsade de pointes, respiratory depression, hepatic adverse reactions, hypersensitivity reactions, myelosuppression, hypotension, seizures, angioedema, atrial fibrillation, bradycardia, priapism). Reduced concentrations of concomitant drugs may reduce their efficacy. (1.1)
Important Interaction Categories
Concomitant use of Sporanox with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Warfarin and vitamin K antagonists (such as Coumadin (Warfarin Sodium) or Warfarin Generic in our Cardiovascular directory): Concomitant administration may alter prothrombin time and International Normalized Ratio (INR) or have additive effects on hemostasis and bleeding risk. More frequent INR monitoring and clinical observation for bleeding are recommended.
- Digoxin (such as Lanoxin (Digoxin) or Digoxin Generic): Co-administration can affect P-glycoprotein transport or renal clearance of digoxin, altering serum digoxin concentrations. Appropriate clinical and laboratory monitoring of digoxin levels is advised.
- Cyclosporine and calcineurin inhibitors (such as cyclosporine or tacrolimus): Co-administration can alter drug transport (OATP1B1 or P-gp) or CYP metabolism, changing blood levels of either medication or increasing nephrotoxicity and myopathy risks.
- Nonsteroidal anti-inflammatory drugs (NSAIDs in our Pain and inflammation directory, such as Celebrex (Celecoxib) or Meloxicam): Combining NSAIDs with this medication may reduce renal perfusion, diminish antihypertensive or diuretic efficacy, or increase the risk of gastrointestinal bleeding and acute kidney injury.
Side effects
Like all medications, Sporanox can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
- Constipation: Adequate hydration and dietary fiber can help manage mild changes in bowel habits.
- Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
Clinical Trial and Postmarketing Adverse Reactions
Adverse reactions Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. Sporanox ® has been associated with rare cases of serious hepatotoxicity, including liver failure and death. Some of these cases had neither pre-existing liver disease nor a serious underlying medical condition. If clinical signs or symptoms develop that are consistent with liver disease, treatment should be discontinued and liver function testing performed. The risks and benefits of Sporanox ® use should be reassessed. (1.1)
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Store at controlled room temperature 15 °C -25 °C (59 °F -77 °F). Protect from light and moisture. (1.1)
Store Sporanox in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).
Frequently Asked Questions About Sporanox
What is Sporanox and what active ingredient does it contain?
Sporanox is an azole antifungal containing the active pharmaceutical ingredient itraconazole. It is supplied for oral administration and requires a valid prescription where applicable.
How does Sporanox work in the body?
In vitro studies have demonstrated that itraconazole inhibits the cytochrome P450-dependent synthesis of ergosterol, which is a vital component of fungal cell membranes.
What conditions is Sporanox prescribed to treat?
Sporanox is primarily indicated for specified fungal infections and HIV infection. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Sporanox?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Sporanox is administered via the oral route. Take it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Sporanox?
Commonly reported side effects of Sporanox include feeling sick, vomiting, loose stools, constipation, headache, and dizziness. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Sporanox?
Important interaction categories for Sporanox include warfarin, digoxin, cyclosporine, and nonsteroidal anti-inflammatory medicines. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Sporanox be used during pregnancy or breastfeeding?
Official prescribing information highlights pregnancy-related precautions for Sporanox. Inform your healthcare provider immediately if you are pregnant, planning to become pregnant, or breastfeeding so safe treatment options can be evaluated.
Do I need a prescription to buy Sporanox online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Sporanox (Itraconazole) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
Does Sporanox have a generic equivalent (Itraconazole) at a Canada pharmacy?
Currently, Sporanox (Itraconazole) is dispensed in our catalogue as a brand-name formulation. Check our Itraconazole active ingredient hub for updates as licensed generic presentations become available.
How is Sporanox shipped to U.S. residents, and how much does shipping cost?
Sporanox ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Sporanox prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Sporanox prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Sporanox (Itraconazole) are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Sporanox (Itraconazole), Official Prescribing Information. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) MedlinePlus Medical Encyclopedia: Fungal Infections. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (3.1) MedlinePlus Medical Encyclopedia: HIV. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (4.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
